MPT: For CIED Surgery, NOAC Administration Up to Clinician

ACC Conference Reporter

AHA 2017 | ANAHEIM — Patients getting cardiac device surgery -- either to place a new pacemaker or defibrillator, or to change parts of an existing device -- don't necessarily have to have non-vitamin K antagonist oral anticoagulant (NOAC or DOAC) therapy halted for their procedure, according to researchers here. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA17


< Back to Listings